Since 1991, we have been working towards a world free of GI cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs. We put patients with GI cancer at the centre of our research, saving and improving lives by accelerating the pace of discoveries that lead to cures.
We are proud that our independent, patient-centred research has been integral to worldwide changes in medical practice. Our clinical trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases have improved outcomes for people with GI cancer and provided access to cutting-edge treatments and high care support not otherwise available.
We have extended life expectancy for patients with GI cancer by testing:
- Oral chemotherapya cancer treatment that uses drugs to kill or slow the growth of cancer cells, while minimising damage to healthy cells as an alternative to intravenousinto or within a vein therapies.
- New drug treatments.
- Targeted therapies and personalised therapy.
- Preoperative chemo radiation.
- Novel combinations of treatments.
We have improved quality-of-life for patients by:
- Reducing side effects by a different combination of chemotherapies.
- Identifying patients who do not benefit from certain therapies.
- Demonstrating that a shorter duration of treatment is equally efficacious but less toxic in the adjuvant treatment of colorectalrelating to the colon or rectum in the large bowel/intestine cancer.
We have tested new targeted therapies:
- Demonstrating that a drug that acts on tumoura tissue mass that forms from groups of unhealthy cells growth is safe and active in oesophageal cancer.
- Showing that a monoclonal antibodya protein made by the immune system to fight against harmful substances (antigens), such as bacteria or viruses treatment is likely to benefit selected patients with bile duct cancer.
We have established surgical guidelines to:
- Improve survival outcomes for pancreatic cancer patients.
RCA is not affiliated with this organisation. It is the responsibility of the patient and their carer(s) to determine whether this or any other support group or organisation listed on this website may provide some benefit to them.
Location
GI Cancer Institute, Missenden Road, Camperdown NSW, Australia